Smash Notes

Back to Paul Romer on the Pandemic, with Paul Romer.

Why Is the United States So Behind on Covid Testing

Due to regulations and approvals, we are in a short supply of conventional tests. Meanwhile, new kind of tests are not being approved, or if approved, then severely restricted in how they are being used.

Transcript

Paul Romer on the Pandemic ·

From the transcript

Well, PCR is a way to take a sample and then toe amplify the to try and amplify a particular string string of are in a from the virus. So if there's a little bit of that are in a in the sample, this amplifies it up to the point where it's easy to measure and says, Oh yeah, there was are in a from the virus in this sample. So PCR is ah is a way to do that.

Um, androgen tester. Another way to see Oh, yeah, there was a string of that are in a from the virus in the sample. Um, one of the big holdups, as you described it, is that the approved tests require the swabs that, you know, go way up the nose towards the back your throat and there were in short supply. Now, now here we get to the heart of why we haven't expanded testing more rapidly.

See in transcript

EconTalk

More from this episode

  1. Why Are We Seriously Overestimating Covid19 Death RateInstead of measuring Covid-related deaths as a proportion of the infected population, we are measuring it as an average percentage of people who got…
  2. How Do We Move Forward With Covid19 Post LockdownWe have to face the fact that viruses will spread faster than ever before. People want to move around, and it would be un-American to constrain our freedoms.

People

More answers like this

More with Russ Roberts

Related episodes

Plays from this note through the rest of the episode.

Weekly highlights

One letter a week.

The notes worth hearing, with the minute they were said.